Health / Health News

    Subtracting Gravity from Alzheimer's

    NASA | MARCH 12, 2015

    Researchers working with astronauts on the International Space Station are embarking on a mission to discover the origin of Alzheimer’s.



    Among medical researchers, Alzheimer’s is a top priority.


    Researchers believe that Alzheimer’s and similar diseases advance when certain proteins in the brain assemble themselves into long fibers that accumulate and ultimately strangle nerve cells in the brain.

    These fibers take decades to form and accumulate—hence the link between Alzheimer's and aging. In laboratories on Earth, researchers have figured out how to make protein fibers accumulate more quickly, so they can study the process without waiting so long.

    On the space station, accumulated fibers do not collapse under their own weight, which makes the station an even better place to study them.

    However, observations from this experiment alone won’t lead directly to the discovery of a cure. The experiment is geared more towards understanding the way that Alzheimer’s progresses, not towards creating a pill to stop it from happening.

    Eventually, this experiment could lead to the discovery of a method to slow down the rate at which the harmful fibers grow, thereby opening a window for a cure.




    YOU MAY ALSO LIKE

    Superbugs are pathogens, or disease-causing microorganisms, resistant to multiple antibiotics. Such antibiotic resistance is now a major public health concern. Could the answer to this threat be hidden in clays formed in minerals deep in the Earth?
    A study conducted at the São Paulo State University (Unesp) shows that music can intensify the effects of drugs against high blood pressure.
    Multiple Sclerosis is an autoimmune disease in which the immune system attacks the central nervous system. One promising treatment for MS is high-dose immunosuppressive therapy with autologous hematopoietic cell transplant.
    Even when taking in fewer calories and nutrients, humans and other mammals usually remain protected against infectious diseases they have already encountered.
    Scientists from the University of Granada have developed a new pharmacological therapy using a molecule that presents similarities with one of the precursors of coenzyme Q10 (CoQ10).
    Beta-amyloid, a protein implicated in Alzheimer’s disease, appears to help protect mice and worms from infection with bacteria or fungi. The results suggest that Alzheimer’s disease may result from certain infections. If validated, the findings could lead to novel approaches to prevent the disease.

    © 1991-2023 The Titi Tudorancea Bulletin | Titi Tudorancea® is a Registered Trademark | Terms of use and privacy policy
    Contact